• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Natural Alternatives International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits

    6/23/25 4:32:15 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $NAII alert in real time by email
    naii20250620_8k.htm
    false 0000787253 0000787253 2025-06-20 2025-06-20
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    Form 8-K
     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    Date of Report (Date of earliest event reported): June 20, 2025
     
    NATURAL ALTERNATIVES INTERNATIONAL, INC.
    (Exact name of registrant as specified in its charter)
     
    Commission File Number:  000-15701
     
    Delaware
    84-1007839
    (State or other jurisdiction of
    (IRS Employer
    incorporation)
    Identification No.)
     
     
    1535 Faraday Avenue, Carlsbad, CA 92008
    (Address of principal executive offices, including zip code)
     
    760-736-7700
    (Registrant’s telephone number, including area code)
     
    (Former name or former address, if changed since last report)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Exchange Act:
     
    Title of each class
    Trading Symbol(s)
    Name of each exchange on which registered
    Common
    NAII
    NASDAQ
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
     
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
     
     

     
     
    ITEM 1.01
    ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
     
    On June 20, 2025 Natural Alternatives International, Inc., a Delaware corporation, ("NAI") entered into an amended credit facility with Wells Fargo Bank, National Association ("Wells Fargo"). The amended credit facility extends NAI's current credit facility with Wells Fargo to December 31, 2026, decreases the maximum principal amount that can be borrowed from $12,500,000 to $10,000,000, and adds the Company’s powder processing facility in Carlsbad California as security for the amended credit agreement. The Sixth Amendment to Credit Agreement amends the formerly in force Credit Agreement, the Second Modification to Revolving Line of Credit Note modifies the former Revolving Line of Credit Note, and the First Modification of Deed of Trust and Assignment of Rents and Leases modifies the existing Deed of Trust securing a term loan with Wells Fargo that was used in the acquisition of the facility, to also secure the amended Revolving Line of Credit Note. The former Security Agreement by and between NAI and Wells Fargo effective as of July 1, 2019 remains in place.
     
    The foregoing description does not purport to be complete and is qualified in its entirety by the agreements attached hereto as Exhibits 10.40, 10.41 and 10.42, each of which is incorporated herein by reference.
     
    ITEM 2.03.
    CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.
     
    The information provided in Item 1.01 above is hereby incorporated by reference into this Item 2.03.
     
    ITEM 7.01
    REGULATION FD DISCLOSURE.
     
    On June 23, 2025, NAI issued a press release announcing the amendment of its credit facility. A copy of the press release is attached hereto as Exhibit 99.9 and incorporated by reference herein.
     
    ITEM 9.01
    FINANCIAL STATEMENTS AND EXHIBITS.
     
    (d) Exhibits.
     
     
    10.40
    Sixth Amendment to Credit Agreement by and between NAI and Wells Fargo effective as of June 20, 2025.
     
     
    10.41
    Second Amendment to Revolving Line of Credit Note made by NAI for the benefit of Wells Fargo dated June 20, 2025.
     
     
    10.42
    First Modification of Deed of Trust and Assignment of Rents and Leases dated June 20, 2025.
     
     
    99.9
    Press Release dated June 23, 2025.
     
     
    104
    Cover Page Interactive Data File (embedded within the Inline XBRL document)
     
    - 2 -
     
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
    Natural Alternatives International, Inc.
    a Delaware corporation
         
    June 23, 2025
    By:
    /s/ Mike Fortin
    Mike Fortin, Chief Financial Officer
     
    - 3 -
    Get the next $NAII alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NAII

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NAII
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results

    CARLSBAD, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.6 million, or $0.42 per diluted share, on net sales of $34.8 million for the second quarter of fiscal year 2026 compared to a net loss of $2.2 million, or $0.37 per diluted share, in the second quarter of the prior fiscal year. Net sales during the three months ended December 31, 2025, increased $0.7 million, or 2%, to $34.8 million as compared to $34.1 million recorded in the comparable prior year period. During the same period, private-label contract m

    2/13/26 4:30:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International, Inc. Announces 2026 Q1 Results

    CARLSBAD, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $0.3 million, or $0.05 per diluted share, on net sales of $37.7 million for the first quarter of fiscal year 2026 compared to a net loss of $2.0 million, or $0.33 per diluted share, in the first quarter of the prior fiscal year. Net sales during the three months ended September 30, 2025, increased $4.6 million, or 13.8%, to $37.7 million as compared to $33.2 million recorded in the comparable prior year period. During the same period, private-label contract m

    11/12/25 4:44:13 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International, Inc. Announces Fiscal 2025 Q4 and YTD Results

    CARLSBAD, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $7.2 million, or ($1.20) per diluted share, on net sales of $33.9 million for the fourth quarter of fiscal year 2025 compared to a net loss of $1.9 million, or ($0.32) per diluted share, in the fourth quarter of the prior fiscal year. Our net loss for the fourth quarter of fiscal 2025 included non-recurring non-cash charges of $1.4 million related to the settlement of a litigation matter and a $4.8 million valuation allowance against our net deferred tax asse

    9/23/25 4:30:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO/Chairman Ledoux Mark A bought $11,604 worth of shares (4,500 units at $2.58), increasing direct ownership by 3% to 154,721 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    2/20/26 6:05:52 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    CEO/Chairman Ledoux Mark A gifted 10,000 shares, decreasing direct ownership by 6% to 150,221 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    1/5/26 3:09:27 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Dunn Alan G was granted 8,000 shares, increasing direct ownership by 10% to 91,211 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    3/11/25 5:16:26 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    SEC Filings

    View All

    SEC Form 10-Q filed by Natural Alternatives International Inc.

    10-Q - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Filer)

    2/13/26 4:17:10 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Natural Alternatives International Inc.

    SCHEDULE 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)

    1/21/26 1:21:12 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Filer)

    12/17/25 5:13:44 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO/Chairman Ledoux Mark A bought $11,604 worth of shares (4,500 units at $2.58), increasing direct ownership by 3% to 154,721 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    2/20/26 6:05:52 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    Leadership Updates

    Live Leadership Updates

    View All

    Natural Alternatives International Appoints New VP of Global Sales

    CARLSBAD, Calif., July 25, 2023 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII) ), a leading formulator, manufacturer, and marketer of customized nutritional supplements, announced that sales executive Shane Conti has joined the company as the Vice President of Global Sales and will be a key driver of global expansion and growth. Over the course of his 25 plus year career in the domestic and international nutritional supplement industry, Conti has established a proven track record of success in building new business within multiple markets. "Shan

    7/25/23 9:00:00 AM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    NATURAL ALTERNATIVES INTERNATIONAL APPOINTS AARON STARR VICE PRESIDENT FOR CARNOSYN® BRANDS

    CARLSBAD, Calif., April 21, 2022 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), an international leader in custom contract nutritional supplement manufacturing for over four decades, announced Aaron Starr has been promoted to Vice President of CarnoSyn® Brands. In his new role, Starr will be responsible for the leadership of business teams and for overseeing operational performance and the advancement of CarnoSyn® Brands. "I am pleased to announce Aaron Starr has been named Vice President of CarnoSyn® Brands," said Kenneth Wolf, President and Chief Operating Officer, Natural Alternatives International. "Aaron has been a valued member of our team for many year

    4/21/22 5:00:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Neptune Wellness Appoints Randy Weaver as Interim Chief Financial Officer and Retains Dr. Toni Rinow as Chief Operating Officer

    LAVAL, QC, Sept. 27, 2021 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ:NEPT) (TSX:NEPT), a diversified and fully integrated health and wellness company focused on plant-based, sustainable and purpose-driven lifestyle brands, today announced the appointment of Randy Weaver as Interim Chief Financial Officer while retaining Dr. Toni Rinow as Chief Operating Officer. Mr. Weaver joins Neptune as Interim Chief Financial Officer with a successful track record of leading numerous CPG companies as a senior executive, bringing the knowledge and e

    9/27/21 7:30:00 AM ET
    $NAII
    $NEPT
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $NAII
    Financials

    Live finance-specific insights

    View All

    Natural Alternatives International, Inc. Announces 2022 Q1 Results

    CARLSBAD, Calif., Nov. 9, 2021 /PRNewswire/ -- -Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $3.3 million, or $0.51 per diluted share, on net sales of $38.3 million for the first quarter of fiscal year 2022 compared to net income of $2.3 million, or $0.35 per diluted share, in the first quarter of the prior fiscal year.  Net sales during the three months ended September 30, 2021 decreased $1.4 million, or 3.5%, to $38.3 million as compared to $39.7 million recorded in the comparable prior year period.  During the same period, private-label contract man

    11/9/21 4:30:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International, Inc. Announces 2021 Q3 and YTD Results

    CARLSBAD, Calif., May 13, 2021 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $1.9 million, or $0.30 per diluted share, on net sales of $46.3 million for the third quarter of fiscal year 2021 compared to a net loss of $4.0 million, or $0.61 per diluted share, in the third quarter of the prior fiscal year.  Our results for the third quarter of fiscal 2020 included the negative impact of a $4.3 million accounts receivable and inventory reserve related to a former customer, which was not repeated in the third quarter of fiscal 2021.  Net s

    5/13/21 4:30:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Natural Alternatives International Inc. (Amendment)

    SC 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)

    2/13/24 10:37:08 AM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Natural Alternatives International Inc. (Amendment)

    SC 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)

    2/9/24 9:59:14 AM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Natural Alternatives International Inc. (Amendment)

    SC 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)

    2/5/24 8:25:38 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care